DSCAM and breast carcinoma: Finally, DSCAM-AS1 was already described in a cDNA library of MCF-7 cells subtracted with a benign cell line and designated as M41, and reported as expressed at higher levels in breast cancer than in normal tissue and benign lesions [32].